Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Role of chemotherapy in the treatment of metastatic breast cancer patients

Professors Joseph Gligorov, Yen-Shen Lu, Chris Twelves and Dr Reshma Mahtani
Role of chemotherapy in the treatment of metastatic breast cancer patients ( Professors Joseph Gligorov, Yen-Shen Lu, Chris Twelves and Dr Reshma Mahtani )
10 Dec 2018

The combined analysis of carfilzomib trials for multiple myeloma

Prof Maria-Victoria Mateos - University of Salamanca, Salamanca, Spain
The combined analysis of carfilzomib trials for multiple myeloma ( Prof Maria-Victoria Mateos - University of Salamanca, Salamanca, Spain )
7 Dec 2018

ECHELON-2: Study into brentuximab vedotin and CHP versus CHOP in the frontline treatment of patients with T-Cell lymphomas

Dr Lorenz Trümper - Georg August University, Göttingen, Germany
ECHELON-2: Study into brentuximab vedotin and CHP versus CHOP in the frontline treatment of patients with T-Cell lymphomas ( Dr Lorenz Trümper - Georg August University, Göttingen, Germany )
6 Dec 2018

Matched targeted therapy for paediatric patients with relapsed, refractory or high-risk leukemias

Dr Yana Pikman - Dana Farber Cancer Institute, Boston, USA
Matched targeted therapy for paediatric patients with relapsed, refractory or high-risk leukemias ( Dr Yana Pikman - Dana Farber Cancer Institute, Boston, USA )
6 Dec 2018

AMG 330: an anti-CD33 bispecific T-Cell engager antibody construct in relapsed/refractory AML

Prof Marion Subklewe - University of Munich, Munich, Germany
AMG 330: an anti-CD33 bispecific T-Cell engager antibody construct in relapsed/refractory AML ( Prof Marion Subklewe - University of Munich, Munich, Germany )
6 Dec 2018

Landscape change with oral proteasome maintenance in multiple myeloma patients

Prof Maria-Victoria Mateos, Prof Wee Joo Chng, Prof Meral Beksac and Dr Sagar Lonial
Landscape change with oral proteasome maintenance in multiple myeloma patients ( Prof Maria-Victoria Mateos, Prof Wee Joo Chng, Prof Meral Beksac and Dr Sagar Lonial )
3 Dec 2018

Patient treatment preferences in relapsed/refractory multiple myeloma

Dr Joseph Mikhael, Prof James Chim and Prof Evangelos Terpos
Patient treatment preferences in relapsed/refractory multiple myeloma ( Dr Joseph Mikhael, Prof James Chim and Prof Evangelos Terpos )
3 Dec 2018

The importance of NF-kB pathway in myeloma

Dr Nizar Bahlis - University of Calgary, Calgary, Canada
The importance of NF-kB pathway in myeloma ( Dr Nizar Bahlis - University of Calgary, Calgary, Canada )
3 Dec 2018

Multiple myeloma highlights and more from ASH 2018

Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France
Multiple myeloma highlights and more from ASH 2018 ( Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France )
3 Dec 2018

Results of the Beat AML umbrella study for previously untreated acute myeloid leukaemia

Dr Amy Burd - Leukemia and Lymphoma Society, White Plains, USA
Results of the Beat AML umbrella study for previously untreated acute myeloid leukaemia ( Dr Amy Burd - Leukemia and Lymphoma Society, White Plains, USA )
3 Dec 2018

ASH 2018: Expert overview of the latest in CLL, ALL and AML

Prof Robin Foa - University of Rome, Rome, Italy
ASH 2018: Expert overview of the latest in CLL, ALL and AML ( Prof Robin Foa - University of Rome, Rome, Italy )
3 Dec 2018

ACT-1: Addition of alemtuzumab to a CHOP backbone for young patients with T-cell lymphoma

Dr Owen O'Connor - Columbia University Medical Centre, New York, USA
ACT-1: Addition of alemtuzumab to a CHOP backbone for young patients with T-cell lymphoma ( Dr Owen O'Connor - Columbia University Medical Centre, New York, USA )
2 Dec 2018